Physician profile
Ryan Michael Garcia
NPI 1063626877
$381,168.87
in general payments reported to CMS, 2019-2025
16 companies · $85K in 2025
The $85K reported for 2025 was more than what 99% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $33K · 2021: $71K · 2022: $44K · 2023: $59K · 2024: $32K · 2025: $85K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $122K · Travel and Lodging: $29K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $3,738 · Honoraria: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $121,845.50 |
| Travel and Lodging | $29,078.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,925.00 |
| Food and Beverage | $3,737.65 |
| Honoraria | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $312,023.11 | 2019-2025 | Integra, Cytal, Primatrix |
| Acumed LLC | $66,938.26 | 2019-2025 | Acumed, Acumed, Innate Implant |
| Synthes Gmbh | $500.00 | 2022 | |
| Curvafix, INC. | $500.00 | 2024 | Curvafix Im Implant |
| Axogen | $366.73 | 2019-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Field Orthopaedics Pty LTD | $133.47 | 2021 | |
| Trice Medical, INC. | $130.89 | 2023 | |
| Osteomed LLC | $121.83 | 2021 | |
| Endo Pharmaceuticals INC. | $104.15 | 2019-2020 | |
| Ossur Americas, INC. | $76.51 | 2024 | I-Digits Quantum |
| Peerless Surgical INC. | $74.61 | 2019-2023 | |
| Allergan, INC. | $73.41 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $56.94 | 2023 | Uzedy, Austedo Xr |
| Depuy Synthes Sales INC. | $30.40 | 2021 | |
| Exsomed Corporation | $23.93 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $14.63 | 2023 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.